SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-166939
Filing Date
2024-06-24
Accepted
2024-06-24 16:06:05
Documents
14
Period of Report
2024-06-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d853953d8k.htm   iXBRL 8-K 36219
  Complete submission text file 0001193125-24-166939.txt   191181

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rvmdw-20240620.xsd EX-101.SCH 3911
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvmdw-20240620_def.xml EX-101.DEF 13294
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvmdw-20240620_lab.xml EX-101.LAB 21820
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvmdw-20240620_pre.xml EX-101.PRE 14198
17 EXTRACTED XBRL INSTANCE DOCUMENT d853953d8k_htm.xml XML 5511
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39219 | Film No.: 241064293
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)